Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa for BCI Efficacy
NCT06729658Phase 1Completed
- Sponsor
- Max Planck Institute for Human Cognitive and Brain Sciences
- Start
- Oct 2017
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in stroke comparing Interventional group - Levodopa with Control group - Placebo (2 arms). Primary endpoints: Changes in brain structure as assessed by MTsat, Changes in brain structure as assessed by PD and 9 more. Started Oct 2017; status: completed.
02
Drugs
levodopa + benserazide
03
Conditions
stroke
Beyond the preview
Go deeper on NCT06729658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06729658.